Treatment Protocol

Levetiracetam use should be considered to decrease seizure frequency as add-on therapy for TR GTC seizures and for TR JME

For LGS, RFN use should be considered established as effective to decrease seizure frequency as add-on therapy

And CLB use should be considered

For add-on therapy for TR focal epilepsy, LEV use should be considered to decrease seizure frequency

ZNS use should be considered to decrease seizure frequency

And OXC use should be considered to decrease seizure frequency

Data are unavailable on the efficacy of CLB, ESL, LCM, PER, PGB, RFN, TGB, or VGB as add-on therapy for the treatment of these children or adolescents